StockData
Inmune Bio, Inc. logo

Inmune Bio, Inc. (INMB) stock

INMBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$1.05+0.00 (0.00%)

Close on Nov 13, 2026Market cap $29.14MP/E –Yield –

Inmune Bio statistics

61 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Sep 30, 2026
Share price as of
Nov 13, 2026

Valuation ratiosIndustry

Market Cap
$29.14M
$272.32M
Enterprise Value
$12.81M
$146.23M
PB Ratio
1.61
2.00
P/TBV Ratio
1.61
2.22

Share statisticsIndustry

Shares Change (YoY)
13.8%
10.8%
Shares Change (QoQ)
0.95%
0.50%
Float
23M
49M
Shares Held by Insiders
16.7%
11.7%
Shares Held by Institutions
15.7%
56.4%

Short sellingIndustry

Short Interest
3M
–
Short Interest Change
-7.89%
-0.80%
Short % of Float
11.5%
9.01%
Short % of Shares Outstanding
9.58%
6.30%
Days to Cover
14.40
5.15

Stock price statisticsIndustry

52-Week High
$2.60
–
52-Week Low
$1.01
–
20-Day Moving Average
$1.35
–
50-Day Moving Average
$1.76
–
200-Day Moving Average
$1.61
–
Average True Range (14)
$0.11
–
Price Change (1 Week)
-7.08%
-1.15%
Price Change (1 Month)
-36.4%
-4.87%
Price Change (3 Months)
-50.7%
-21.0%
Price Change (6 Months)
-32.3%
-20.6%
Price Change (YTD)
-32.7%
-23.6%
Price Change (1 Year)
-30.9%
-22.4%
Price Change (3 Years)
-84.7%
-29.5%
Price Change (5 Years)
-92.8%
-77.9%
Average Volume (10 Days)
391,484
–
Average Volume (20 Days)
289,217
–
Average Volume (90 Days)
376,934
–
Relative Volume
1.23
0.70
Relative Strength Index (14)
21.9
43.4
Volatility (1 Year)
74.1%
80.1%
Beta (5 Years)
1.32
1.07

Returns on capitalIndustry

Return on Equity (ROE)
-76.7%
-49.9%
Return on Assets (ROA)
-60.8%
-40.6%
Return on Capital Employed (ROCE)
-95.6%
-37.9%

Financial positionIndustry

Current Ratio
6.41
3.30
Quick Ratio
6.01
2.39

GrowthIndustry

Revenue Growth (3Y CAGR)
-48.9%
2.25%
Revenue Growth (5Y CAGR)
35.4%
6.41%

EfficiencyIndustry

Profits Per Employee
-$2.78M
-$689.41K
Employee Count
6
74
WACC
11.7%
10.2%

Income statement (TTM)Industry

Operating Income
-$17.77M
-$21.37M
Net Income
-$16.67M
-$22.35M
EBITDA
-$17.77M
-$17.21M
EPS (Diluted)
-$0.62
-$0.76

Balance sheetIndustry

Net Cash (Debt)
$16.33M
$17.76M
Net Cash Per Share
$0.59
$0.80
Equity (Book Value)
$18.07M
$53.89M
Book Value Per Share
$0.65
$1.50
Tangible Book Value
$18.07M
$27.13M
Working Capital
$15.79M
$79.99M

Cash flow (TTM)Industry

Operating Cash Flow
-$12.91M
-$12.38M

Dividends and yieldsIndustry

Earnings Yield
-57.2%
-21.8%

Scores and fair valueIndustry

Altman Z-Score
-11.10
0.23
Piotroski F-Score
4
4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

PeriodINMBS&P 500DifferenceINMB per yearS&P 500 per year
1 month-37.5%-3.0%−34.5 pts
3 months-49.5%-2.8%−46.7 pts
Year to date-32.7%+11.5%−44.2 pts
1 year-26.6%+13.5%−40.0 pts
3 years-85.7%+77.7%−163.4 pts-47.7%+21.1%
5 years-92.8%+72.6%−165.4 pts-40.9%+11.5%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

3M INMB shares were sold short on Oct 30, 2026, down 7.9% from the previous report, or 11.50% of the shares available to trade. At recent volumes it would take 14.4 days to buy them back. Over the last 20 sessions, 44.8% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20262,658,847-7.9%184,69314.4
Oct 15, 20262,886,615+8.6%349,8148.3
Sep 30, 20262,657,727+18.1%381,6207.0
Sep 15, 20262,251,105+3.1%289,1777.8
Aug 31, 20262,183,845+3.9%349,1006.3
Aug 14, 20262,102,037-4.6%421,8465.0
Jul 31, 20262,203,321-7.6%331,6256.6
Jul 15, 20262,384,123-22.3%1,080,4692.2
Jun 30, 20263,068,023-16.4%1,898,4581.6
Jun 15, 20263,668,941-0.6%325,48411.3
May 29, 20263,689,456+1.3%256,56014.4
May 15, 20263,641,628+2.9%681,6675.3

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?